Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, stage B prostate adenocarcinomas
収録刊行物
-
- Am J Pathol
-
Am J Pathol 145 287-293, 1994
Am J Pathol 145 287-293, 1994